Request Sample

Global COVID-19 Antibody Rapid Test Kits Market Research Report 2023

SKU ID : QYR-25150710 | Publishing Date : 10-Oct-2023 | No. of pages : 91

In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.

According to Researcher's new survey, global COVID-19 Antibody Rapid Test Kits market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COVID-19 Antibody Rapid Test Kits market research.

Key manufacturers engaged in the COVID-19 Antibody Rapid Test Kits industry include RayBiotech Life, Aurora Biomed, SD Biosensor, Abingdon Health, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda and Roche Diagnostics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of COVID-19 Antibody Rapid Test Kits were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole COVID-19 Antibody Rapid Test Kits market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global COVID-19 Antibody Rapid Test Kits market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company



RayBiotech Life

Aurora Biomed

SD Biosensor

Abingdon Health

INSTI

CTK Biotech

SBL Testing Technologies

Biopanda

Roche Diagnostics

TestLine Clinical Diagnostics

Assay Genie

Nadal-test

Panodyne

Luminex



Segment by Type



IgG Test

IgM Test

Others



Segment by Application



Hospital

Company

School

Home

Others


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

The COVID-19 Antibody Rapid Test Kits report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers’ Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers’ Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Contact Information

24/7 Research Support

Phone: +1 (888) 690-5999

[email protected]